1
|
McGill LD, Blue J, Powers B. Report of the Ad Hoc Committee on Oncology to the ACVP Membership and Interested Pathology Community. Vet Pathol 2016; 39:525-8. [PMID: 12243461 DOI: 10.1354/vp.39-5-525] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
2
|
McGill LD. Book Review: Lymphoma in Dogs and Cats. Vet Pathol 2016. [DOI: 10.1354/vp.42-6-860-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
3
|
Avula M, Jones D, Rao AN, McClain D, McGill LD, Grainger DW, Solzbacher F. Local release of masitinib alters in vivo implantable continuous glucose sensor performance. Biosens Bioelectron 2015; 77:149-56. [PMID: 26402593 DOI: 10.1016/j.bios.2015.08.059] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2015] [Revised: 08/24/2015] [Accepted: 08/25/2015] [Indexed: 11/25/2022]
Abstract
Continuous glucose monitoring (CGM) sensors are often advocated as a clinical solution to improve long-term glycemic control in the context of diabetes. Subcutaneous sensor inflammatory response, fouling and fibrous encapsulation resulting from the host foreign body response (FBR) reduce sensor sensitivity to glucose, eventually resulting in sensor performance compromise and device failure. Several combination device strategies load CGM sensors with drug payloads that release locally to tissue sites to mitigate FBR-mediated sensor failure. In this study, the mast cell-targeting tyrosine kinase inhibitor, masitinib, was released from degradable polymer microspheres delivered from the surfaces of FDA-approved human commercial CGM needle-type implanted sensors in a rodent subcutaneous test bed. By targeting the mast cell c-Kit receptor and inhibiting mast cell activation and degranulation, local masitinib penetration around the CGM to several hundred microns sought to reduce sensor fibrosis to extend CGM functional lifetimes in subcutaneous sites. Drug-releasing and control CGM implants were compared in murine percutaneous implant sites for 21 days using direct-wire continuous glucose reporting. Drug-releasing implants exhibited no significant difference in CGM fibrosis at implant sites but showed relatively stable continuous sensor responses over the study period compared to blank microsphere control CGM implants.
Collapse
Affiliation(s)
- M Avula
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA
| | - D Jones
- Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA
| | - A N Rao
- Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA
| | - D McClain
- Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, USA
| | - L D McGill
- Associated Regional and University Pathologist Laboratories, University of Utah, Salt Lake City, UT 84112, USA
| | - D W Grainger
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA; Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.
| | - F Solzbacher
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA; Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, UT 84112, USA
| |
Collapse
|
4
|
Avula MN, Rao AN, McGill LD, Grainger DW, Solzbacher F. Foreign body response to subcutaneous biomaterial implants in a mast cell-deficient Kit(w-Sh) murine model. Acta Biomater 2014; 10:1856-63. [PMID: 24406200 DOI: 10.1016/j.actbio.2013.12.056] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2013] [Revised: 12/11/2013] [Accepted: 12/26/2013] [Indexed: 12/17/2022]
Abstract
Mast cells (MCs)_are recognized for their functional role in wound-healing and allergic and inflammatory responses - host responses that are frequently detrimental to implanted biomaterials if extended beyond acute reactivity. These tissue reactions impact especially on the performance of sensing implants such as continuous glucose monitoring (CGM) devices. Our hypothesis that effective blockade of MC activity around implants could alter the host foreign body response (FBR) and enhance the in vivo lifetime of these implantable devices motivated this study. Stem cell factor and its ligand c-KIT receptor are critically important for MC survival, differentiation and degranulation. Therefore, an MC-deficient sash mouse model was used to assess MC relationships to the in vivo performance of CGM implants. Additionally, local delivery of a tyrosine kinase inhibitor (TKI) that inhibits c-KIT activity was also used to evaluate the role of MCs in modulating the FBR. Model sensor implants comprising polyester fibers coated with a rapidly dissolving polymer coating containing drug-releasing degradable microspheres were implanted subcutaneously in sash mice for various time points, and the FBR was evaluated for chronic inflammation and fibrous capsule formation around the implants. No significant differences were observed in the foreign body capsule formation between control and drug-releasing implant groups in MC-deficient mice. However, fibrous encapsulation was significantly greater around the drug-releasing implants in sash mice compared to drug-releasing implants in wild-type (e.g. MC-competent) mice. These results provide insights into the role of MCs in the FBR, suggesting that MC deficiency provides alternative pathways for host inflammatory responses to implanted biomaterials.
Collapse
Affiliation(s)
- M N Avula
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA
| | - A N Rao
- Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA
| | - L D McGill
- Associated Regional and University Pathologist Laboratories, University of Utah, Salt Lake City, UT 84112, USA
| | - D W Grainger
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA; Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.
| | - F Solzbacher
- Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA; Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, UT 84112, USA
| |
Collapse
|
5
|
Sadekar S, Thiagarajan G, Bartlett K, Hubbard D, Ray A, McGill LD, Ghandehari H. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin. Int J Pharm 2013; 456:175-85. [PMID: 23933439 DOI: 10.1016/j.ijpharm.2013.07.071] [Citation(s) in RCA: 70] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2013] [Revised: 07/16/2013] [Accepted: 07/19/2013] [Indexed: 12/27/2022]
Abstract
Oral delivery of camptothecin has a treatment advantage but is limited by low bioavailability and gastrointestinal toxicity. Poly(amido amine) or PAMAM dendrimers have shown promise as intestinal penetration enhancers, drug solubilizers and drug carriers for oral delivery in vitro and in situ. There have been very limited studies in vivo to evaluate PAMAM dendrimers for oral drug delivery. In this study, camptothecin (5 mg/kg) was formulated and co-delivered with cationic, amine-terminated PAMAM dendrimer generation 4.0 (G4.0) (100 and 300 mg/kg) and anionic, carboxylate-terminated PAMAM generation 3.5 (G3.5) (300 and 1000 mg/kg) in CD-1 mice. Camptothecin associated to a higher extent with G4.0 than G3.5 in the formulation, attributed to an electrostatic interaction on the surface of G4.0. Both PAMAM G4.0 and G3.5 increased camptothecin solubilization in simulated gastric fluid and caused a 2-3 fold increase in oral absorption of camptothecin when delivered at 2 h. PAMAM G4.0 and G3.5 did not increase mannitol transport suggesting that the oral absorption of camptothecin was not due to tight junction modulation. Histologic observations of the epithelial layer of small intestinal segments of the gastrointestinal tract (GIT) at 4 h post dosing supported no evidence of toxicity at the evaluated doses of PAMAM dendrimers. This study demonstrates that both cationic (G.4) and anionic (G3.5) PAMAM dendrimers were effective in enhancing the oral absorption of camptothecin. Results suggest that drug inclusion in PAMAM interior controlled solubilization in simulated gastric and intestinal fluids, and increased oral bioavailability.
Collapse
Affiliation(s)
- S Sadekar
- Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA; Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT 84112, USA
| | | | | | | | | | | | | |
Collapse
|
6
|
Kamstock DA, Ehrhart EJ, Getzy DM, Bacon NJ, Rassnick KM, Moroff SD, Liu SM, Straw RC, McKnight CA, Amorim RL, Bienzle D, Cassali GD, Cullen JM, Dennis MM, Esplin DG, Foster RA, Goldschmidt MH, Gruber AD, Hellmén E, Howerth EW, Labelle P, Lenz SD, Lipscomb TP, Locke E, McGill LD, Miller MA, Mouser PJ, O’Toole D, Pool RR, Powers BE, Ramos-Vara JA, Roccabianca P, Ross AD, Sailasuta A, Sarli G, Scase TJ, Schulman FY, Shoieb AM, Singh K, Sledge D, Smedley RC, Smith KC, Spangler WL, Steficek B, Stromberg PC, Valli VE, Yager J, Kiupel M. Recommended Guidelines for Submission, Trimming, Margin Evaluation, and Reporting of Tumor Biopsy Specimens in Veterinary Surgical Pathology. Vet Pathol 2010; 48:19-31. [DOI: 10.1177/0300985810389316] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- D. A. Kamstock
- Flint Animal Cancer Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO
| | - E. J. Ehrhart
- Flint Animal Cancer Center, Department of Microbiology, Immunology & Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO
| | - D. M. Getzy
- IDEXX Reference Laboratories, Inc., Westminster, CO
| | - N. J. Bacon
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL
| | - K. M. Rassnick
- College of Veterinary Medicine, Cornell University, Ithaca, NY
| | | | | | - R. C. Straw
- Brisbane Veterinary Specialist Centre, Brisbane, Queensland, Australia
| | | | - R. L. Amorim
- School of Veterinary Medicine, Sao Paulo State University, Botucatu, SP, Brazil
| | - D. Bienzle
- Department of Pathobiology, University of Guelph, Guelph, ON, Canada
| | - G. D. Cassali
- Laboratório de Patologia Comparada, Departamento de Patologia Geral, Belo Horizonte, MG, Brazil
| | - J. M. Cullen
- Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC
| | - M. M. Dennis
- Faculty of Veterinary Science, University of Sydney, Camden, New South Wales, Australia
| | - D. G. Esplin
- Animal Reference Pathology Division, ARUP Laboratories, Salt Lake City, UT
| | - R. A. Foster
- Department of Pathobiology, University of Guelph, Guelph, ON, Canada
| | - M. H. Goldschmidt
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
| | - A. D. Gruber
- Department of Veterinary Pathology, Freie Universität, Berlin
| | - E. Hellmén
- Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry, Uppsala, Sweden
| | - E. W. Howerth
- Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA
| | | | - S. D. Lenz
- Animal Disease Diagnostic Laboratory, Department of Comparative Pathobiology, Purdue University, West Lafayette, IN
| | - T. P. Lipscomb
- Marshfield Labs, Veterinary Services, Marshfield, WI and Department of Veterinary Pathology, Armed Forces Institute of Pathology, Washington, DC
| | - E. Locke
- Antech Diagnostics, Guelph, ON, Canada
| | - L. D. McGill
- Animal Reference Pathology Division, ARUP Laboratories, Salt Lake City, UT
| | - M. A. Miller
- Animal Disease Diagnostic Laboratory, Department of Comparative Pathobiology, Purdue University, West Lafayette, IN
| | | | - D. O’Toole
- Wyoming State Veterinary Laboratory, University of Wyoming, Laramie, WY
| | - R. R. Pool
- Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX
| | - B. E. Powers
- Colorado State Veterinary Diagnostic Laboratory, Colorado State University, Fort Collins, CO
| | - J. A. Ramos-Vara
- Animal Disease Diagnostic Laboratory, Department of Comparative Pathobiology, Purdue University, West Lafayette, IN
| | - P. Roccabianca
- Section of Anatomical Pathology and Avian Pathology, Faculty of Veterinary Medicine, Milano, Italy
| | - A. D. Ross
- Registered Specialist Anatomical Pathologist, Frankston, Australia
| | - A. Sailasuta
- Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Pratumwan, Bangkok, Thailand
| | - G. Sarli
- Pathological Anatomy Laboratory Service, Department of Veterinary Medicine, University of Bologna, Italy
| | - T. J. Scase
- Veterinary Public Health and Animal Pathology, Faculty of Bridge Pathology Ltd. Clifton, Bristol, UK
| | - F. Y. Schulman
- Marshfield Labs, Veterinary Services, Marshfield, WI and Department of Veterinary Pathology, Armed Forces Institute of Pathology, Washington, DC
| | - A. M. Shoieb
- Pfizer Ltd, Drug Safety and Research Development, Sandwich Kent, UK
| | - K. Singh
- Veterinary Diagnostic Laboratory & Department of Pathobiology, University of Illinois, Urbana, IL
| | - D. Sledge
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, Lansing, MI
| | - R. C. Smedley
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, Lansing, MI
| | - K. C. Smith
- Department of Pathology and Infectious Diseases, Royal Veterinary College, Hatfield, Herts, UK
| | | | - B. Steficek
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, Lansing, MI
| | - P. C. Stromberg
- Department of Veterinary Biosciences, College of Veterinary Medicine, Ohio State University, Columbus, OH
| | | | - J. Yager
- Antech Diagnostics, Guelph, ON, Canada
| | - M. Kiupel
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, Lansing, MI
| |
Collapse
|
7
|
Webster JD, Dennis MM, Dervisis N, Heller J, Bacon NJ, Bergman PJ, Bienzle D, Cassali G, Castagnaro M, Cullen J, Esplin DG, Peña L, Goldschmidt MH, Hahn KA, Henry CJ, Hellmén E, Kamstock D, Kirpensteijn J, Kitchell BE, Amorim RL, Lenz SD, Lipscomb TP, McEntee M, McGill LD, McKnight CA, McManus PM, Moore AS, Moore PF, Moroff SD, Nakayama H, Northrup NC, Sarli G, Scase T, Sorenmo K, Schulman FY, Shoieb AM, Smedley RC, Spangler WL, Teske E, Thamm DH, Valli VE, Vernau W, Euler HV, Withrow SJ, Weisbrode SE, Yager J, Kiupel M. Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology. Vet Pathol 2010; 48:7-18. [DOI: 10.1177/0300985810377187] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- J. D. Webster
- Molecular Pathology Unit, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
| | - M. M. Dennis
- Faculty of Veterinary Science, University of Sydney, Camden, New South Wales, Australia
| | - N. Dervisis
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan
| | - J. Heller
- School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia
| | - N. J. Bacon
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida
| | | | - D. Bienzle
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada
| | - G. Cassali
- Department of General Pathology, Institute of Biological Science, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
| | - M. Castagnaro
- Department of Public Health, Comparative Pathology, and Veterinary Hygiene, University of Padua, Padua, Italy
| | - J. Cullen
- Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina
| | | | - L. Peña
- Department of Animal Medicine, Surgery and Pathology, Veterinary School, University Complutense of Madrid, Madrid, Spain
| | - M. H. Goldschmidt
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - K. A. Hahn
- Hill’s Pet Nutrition, Inc, Topeka, Kansas
| | - C. J. Henry
- Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri
| | - E. Hellmén
- Department of Anatomy, Physiology, and Biochemistry, Swedish University of Agricultural Sciences, Uppsala, Sweden
| | - D. Kamstock
- Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine, Colorado State University, Fort Collins, Colorado
| | - J. Kirpensteijn
- Department of Companion Animal Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
| | - B. E. Kitchell
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan
| | - R. L. Amorim
- Department of Veterinary Clinics, Veterinary Medical School, UNESP, Sao Paulo State University, Botucatu, Sao Paulo, Brazil
| | - S. D. Lenz
- Depatment of Comparative Pathobiology, School of Veterinary Medicine, Purdue University, West Lafayette, Indiana
| | - T. P. Lipscomb
- Department of Veterinary Pathology, Armed Forces Institute of Pathology, Washington, DC
| | - M. McEntee
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York
| | | | | | | | - A. S. Moore
- Faculty of Veterinary Science, University of Sydney, Sydney, New South Wales, Australia
| | - P. F. Moore
- Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California
| | | | - H. Nakayama
- Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo, Japan
| | - N. C. Northrup
- Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, Georgia
| | - G. Sarli
- Department of Veterinary Public Health and Animal Pathology, Faculty of Veterinary Medicine, University of Bologna, Bologna, Italy
| | - T. Scase
- Bridge Pathology Ltd, Bristol, United Kingdom
| | - K. Sorenmo
- Ryan Veterinary Hospital, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - F. Y. Schulman
- Department of Veterinary Pathology, Armed Forces Institute of Pathology, Washington, DC
| | - A. M. Shoieb
- Pfizer, Drug Safety and Research Development, Sandwich, United Kingdom
| | - R. C. Smedley
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan
| | | | - E. Teske
- Department of Companion Animal Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
| | - D. H. Thamm
- Animal Cancer Center, Colorado State University, Fort Collins, Colorado
| | - V. E. Valli
- VDx Veterinary Diagnostics, Davis, California
| | - W. Vernau
- Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, California
| | - H. von Euler
- Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden
| | - S. J. Withrow
- Animal Cancer Center, Colorado State University, Fort Collins, Colorado
| | - S. E. Weisbrode
- Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio
| | - J. Yager
- Yager-Best Histovet, Guelph, Ontario, Canada
| | - M. Kiupel
- Diagnostic Center for Population and Animal Health, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan
- Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan
| |
Collapse
|
8
|
McGill LD. Book Review: Color Atlas of Farm Animal Dermatology. Vet Pathol 2007. [DOI: 10.1354/vp.44-4-559-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
9
|
McGill LD. Book Review: Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis. Vet Pathol 2006. [DOI: 10.1354/vp.43-4-584-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- L. D. McGill
- Animal Reference Pathology Div. ARUP Laboratories, Inc. Salt Lake City, UT
| |
Collapse
|
10
|
Affiliation(s)
- M J Hendrick
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104
| | | | | | | |
Collapse
|
11
|
Esplin DG, McGill LD, Meininger AC, Wilson SR. Postvaccination sarcomas in cats. J Am Vet Med Assoc 1993; 202:1245-7. [PMID: 8496079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- D G Esplin
- Animal Reference Pathology Division, Associated Regional and University Pathologists, Salt Lake City, UT 84108
| | | | | | | |
Collapse
|
12
|
Abstract
Freshly harvested equine skin incised with an electrosurgical unit, a radiosurgical device, or a carbon dioxide (CO2) laser was examined by light microscopy to determine the extent of thermal injury caused by each instrument. There was no significant difference between the thermal injury caused by the electrosurgical unit in the pure-cut mode and the CO2 laser in the superpulse mode, or between the electrosurgical unit and the radiosurgical device in the fully filtered cut mode. However, thermal injury caused by the CO2 laser was significantly less than that caused by the radiosurgical device. The amount of thermal injury in this in vitro study was similar to that found in vivo with other species.
Collapse
Affiliation(s)
- S E Palmer
- New Jersey Equine Clinic, Clarksburg 08510
| | | |
Collapse
|
13
|
Abstract
A high dose (550 mg/kg) of 3-methylindole (3MI) specifically damaged pulmonary tissue in Swiss-Webster mice without causing any hepatic or renal necrosis. When a glutathione depleter, L-buthionine-(S,R)-sulfoximine (BSO, 1.0 mmol/kg), was administered to mice 3 hr before a low dose of 3-methylindole (75 mg/kg), significant renal damage was observed by histopathological examination after 4 hr. The nephrotoxicity occurred without any observable pathological damage to lung tissues. Increased doses of BSO caused dose-dependent increases in renal toxicity. A low dose of BSO (1.0 mmol/kg) caused no depletion of renal glutathione levels, a large depletion of hepatic glutathione levels (60% of control values), and much larger increases in covalent binding of [methyl-14C]3-methylindole to renal tissues (3.4-fold) than to hepatic tissues (1.5-fold) or pulmonary tissues (2.1-fold). No evidence of hepatic or pulmonary histopathological damage was observed at any dose of BSO with 75 mg/kg 3MI. These results indicate that a shift in organ selectivity of 3MI-induced toxicity from pulmonary to renal sites occurs as a result of glutathione depletion in hepatic tissues. The production of a toxic metabolite in the livers of glutathione-depleted mice that is circulated to susceptible renal cells may be the mechanism of this interesting organ-selective shift in toxicity of 3MI.
Collapse
Affiliation(s)
- G S Yost
- Department of Pharmacology and Toxicology, University of Utah, Salt Lake City
| | | | | |
Collapse
|
14
|
Greve JH, Hanson RL, McGill LD. Treatment of parasitic ascites in a dog. J Am Vet Med Assoc 1979; 174:828-9. [PMID: 500423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
15
|
Rhodes MB, Stair EL, McCullough RA, McGill LD, Mebus CA. Comparison of results using electron microscope, immunodiffusion and fluorescent antibody analyses to detect rotavirus in diarrheic fecal samples of calves. Can J Comp Med 1979; 43:84-9. [PMID: 218708 PMCID: PMC1319943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Seventy-nine diarrheic calf fecal samples were examined by electron microscopy, immunodiffusion and the fluorescent antibody technique for the presence of rotavirus (reovirus-like agent). Thirty-eight (48%) of the samples were positive by electron microscopy, 59% by immunodiffusion and 20% positive by fluorescent antibody technique analyses. Another 9% were suspect-positive by fluorescent antibody technique. Chymotrypsin treatment of the fecal samples increased the ease of observing the viral particles by electron microscopy and also intensified the immunodiffusion arcs obtained. Immunodiffusion analyses using specific antisera to the virus would appear to be a practical method of detecting rotavirus in diarrheic fecal samples.
Collapse
|
16
|
Underdahl NR, Mebus CA, Stair EL, Rhodes MB, McGill LD, Twiehaus MJ. Isolation of transmissible gastroenteritis virus from lungs of market-weight swine. Am J Vet Res 1974; 35:1209-16. [PMID: 4607634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
MESH Headings
- Aerosols
- Animals
- Antigens, Viral
- Coronaviridae/immunology
- Coronaviridae/isolation & purification
- Coronaviridae/ultrastructure
- Fluorescent Antibody Technique
- Gastroenteritis, Transmissible, of Swine/etiology
- Gastroenteritis, Transmissible, of Swine/immunology
- Gastroenteritis, Transmissible, of Swine/microbiology
- Gastroenteritis, Transmissible, of Swine/pathology
- Gastroenteritis, Transmissible, of Swine/transmission
- Germ-Free Life
- Intestines/microbiology
- Lung/microbiology
- Lung/pathology
- Microscopy, Electron
- Swine
Collapse
|
17
|
Gelatt KN, McGill LD, Perman V. Ocular and systemic cryptococcosis in a dog. J Am Vet Med Assoc 1973; 162:370-5. [PMID: 4691372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
18
|
Gelatt KN, McGill LD. Clinical characteristics of microphthalmia with colobomas of the Australian Shepherd Dog. J Am Vet Med Assoc 1973; 162:393-6. [PMID: 4691375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
19
|
Gleiser CA, Stair EL, McGill LD. Diagnosis of bluetongue in cattle by intravascular inoculation of chicken embryos and immunofluorescence. Am J Vet Res 1969; 30:981-6. [PMID: 4307343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|